ES2160727T3 - Parches medicinales para administracion percutanea. - Google Patents
Parches medicinales para administracion percutanea.Info
- Publication number
- ES2160727T3 ES2160727T3 ES95941909T ES95941909T ES2160727T3 ES 2160727 T3 ES2160727 T3 ES 2160727T3 ES 95941909 T ES95941909 T ES 95941909T ES 95941909 T ES95941909 T ES 95941909T ES 2160727 T3 ES2160727 T3 ES 2160727T3
- Authority
- ES
- Spain
- Prior art keywords
- penetration
- skin
- potentiator
- water absorption
- capacity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000035515 penetration Effects 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- 238000010521 absorption reaction Methods 0.000 abstract 3
- 239000010410 layer Substances 0.000 abstract 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000004840 adhesive resin Substances 0.000 abstract 1
- 229920006223 adhesive resin Polymers 0.000 abstract 1
- 239000007933 dermal patch Substances 0.000 abstract 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical group OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 abstract 1
- 229940051250 hexylene glycol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE MUESTRA UN PARCHE CUTANEO TRANSDERMICO PARA ADHERIR A LA PIEL DEL PACIENTE QUE CONSISTE DE UNA CAPA SUPERIOR IMPERMEABLE AL AGUA, UNA CUBIERTA Y, ENTRE LAS DOS, UNA CAPA MULTIPLE LAMINADA FORMADA POR 2 A 5 CAPAS ADHESIVAS, CADA UNA DE LAS CUALES CONTIENE UN INGREDIENTE ACTIVO, UNA RESINA ADHESIVA Y UN POTENCIADOR DE PENETRACION. NINGUNA DE LAS CAPAS CONTIENE AGUA Y CADA UNA DE ELLAS TIENE UNA CAPACIDAD DISTINTA DE ABSORCION DE AGUA: LA CAPA INFERIOR, QUE ENTRARA EN CONTACTO CON LA PIEL, TIENE LA MENOR CAPACIDAD DE ABSORCION DE AGUA, Y LA CAPA SUPERIOR, EN CONTACTO CON LA CAPA IMPERMEABLE, TIENE LA MAYOR CAPACIDAD DE ABSORCION DE AGUA. EL POTENCIADOR DE PENETRACION MENCIONADO ES HEXILENGLICOL, PRESENTE EN UNA CANTIDAD DE 0,5 A 40% POR PESO. EL PARCHE DE LA PRESENTE INVENCION CONTIENE HEXILENGLICOL COMO POTENCIADOR DE PENETRACION, QUE PERMITE POTENCIAR DE MANERA EFICAZ LA PENETRACION DEL INGREDIENTE ACTIVO A TRAVES DE LA PIEL, Y AL MISMO TIEMPO ES SEGURO PARA SU APLICACION CUTANEA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19940036654 | 1994-12-24 | ||
| KR1019950053707A KR100188180B1 (ko) | 1994-12-24 | 1995-12-21 | 경피투여용 패취제제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2160727T3 true ES2160727T3 (es) | 2001-11-16 |
Family
ID=26630794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95941909T Expired - Lifetime ES2160727T3 (es) | 1994-12-24 | 1995-12-23 | Parches medicinales para administracion percutanea. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0746311B1 (es) |
| CN (1) | CN1057906C (es) |
| CA (1) | CA2183960E (es) |
| ES (1) | ES2160727T3 (es) |
| WO (1) | WO1996019976A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE229817T1 (de) * | 1996-10-24 | 2003-01-15 | Alza Corp | Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
| US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
| CN1252004A (zh) * | 1997-04-16 | 2000-05-03 | 久光制药株式会社 | 经皮吸收用基质组合物及含有该基质组合物的可经皮吸收的制剂 |
| DE19834007C1 (de) * | 1998-07-29 | 2000-02-24 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung |
| DE19925613A1 (de) * | 1999-06-04 | 2000-12-07 | Lohmann Therapie Syst Lts | Verbundlaminat und Verfahren zu seiner Herstellung |
| PT1372708E (pt) | 2001-02-13 | 2008-09-29 | Us Gov Sec Army | Vacina para imunização transcutânea |
| EP1381381A1 (en) * | 2001-03-19 | 2004-01-21 | Gregory M. Glenn | Patch for transcutaneous immunization |
| CN101420946B (zh) * | 2006-04-11 | 2011-05-25 | 日绊株式会社 | 含有坦索罗辛的透皮吸收型制剂 |
| JP5097034B2 (ja) * | 2007-07-20 | 2012-12-12 | 日東電工株式会社 | 貼付剤および貼付製剤 |
| EP2191833B1 (en) * | 2007-09-20 | 2013-02-13 | Shiseido Company, Ltd. | Transdermally absorbable preparation |
| CN112206222A (zh) * | 2018-11-09 | 2021-01-12 | 北京德默高科医药技术有限公司 | 含有布洛芬结构类似物的多层经皮给药系统 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
| US5762952A (en) * | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
-
1995
- 1995-12-23 ES ES95941909T patent/ES2160727T3/es not_active Expired - Lifetime
- 1995-12-23 CN CN95191791A patent/CN1057906C/zh not_active Expired - Lifetime
- 1995-12-23 WO PCT/KR1995/000171 patent/WO1996019976A1/en not_active Ceased
- 1995-12-23 CA CA002183960A patent/CA2183960E/en not_active Expired - Fee Related
- 1995-12-23 EP EP95941909A patent/EP0746311B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996019976A1 (en) | 1996-07-04 |
| CA2183960E (en) | 2001-08-21 |
| CA2183960A1 (en) | 1996-07-04 |
| CA2183960C (en) | 1999-07-27 |
| CN1162260A (zh) | 1997-10-15 |
| EP0746311A1 (en) | 1996-12-11 |
| CN1057906C (zh) | 2000-11-01 |
| EP0746311B1 (en) | 2001-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2160727T3 (es) | Parches medicinales para administracion percutanea. | |
| CO5100944A1 (es) | Apositos y vendajes para heridas que comprenden un substrato absorbente y un revestimiento de una composicion | |
| ES2152979T3 (es) | Sistema terapeutico transdermal que contiene estradiol. | |
| YU2694A (sh) | Transdermalni terapeutski sistem za odavanje galantamina | |
| AR064268A1 (es) | Sistema terapeutico transdermico para administracion del principio activo buprenorfina | |
| PT95002A (pt) | Metodo e dispositivo para administracao transdermica de dexmedetomidina | |
| DE60142988D1 (de) | Gerät zur verhinderung und/oder heilung von druckgeschwüren | |
| ES2077530B1 (es) | Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. | |
| ES2054818T3 (es) | Dispositivo mejorado para el suministro transdermal de farmacos. | |
| ES2068897T3 (es) | Una sustancia biocompatible, tromborresistente que comprende hirudina, sus analogos o fragmentos, y metodos para producir la misma. | |
| PT81751B (pt) | Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica | |
| DE69326461D1 (de) | Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung | |
| ES2160623T3 (es) | Composiciones farmaceuticas mejoradas para la penetracion en la piel de piroxicam. | |
| ES2103271T3 (es) | Dispositivo para administrar un agente activo a la piel o a mucosas. | |
| ES2116572T3 (es) | Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion. | |
| YU14394A (sh) | Flaster sa aktivnom supstancom za davanje estradiola na kožu | |
| ES2117152T3 (es) | Sistema terapeutico percutaneo para la aplicacion de 17-beta-estradiol y procedimiento de fabricacion. | |
| NO158891B (no) | Foldbar skillevegg. | |
| US3297032A (en) | Adhesive bandage having container of medicament carried by removable protector strip | |
| US20040161452A1 (en) | Drug-dispensing dressing and composition for treating onychomycosis | |
| ES2007240A6 (es) | Procedimiento para elaborar un preparado farmaceutico que asegura la absorcion transdernal del ingrediente activo. | |
| KR900013993A (ko) | 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도 | |
| AR026038A1 (es) | Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion | |
| BR0109893A (pt) | Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente | |
| AR005011A1 (es) | Articulo absorbente descartable con calce mejorado. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 746311 Country of ref document: ES |